94 related articles for article (PubMed ID: 8755247)
1. Not all Shc's roads lead to Ras.
Bonfini L; Migliaccio E; Pelicci G; Lanfrancone L; Pelicci PG
Trends Biochem Sci; 1996 Jul; 21(7):257-61. PubMed ID: 8755247
[TBL] [Abstract][Full Text] [Related]
2. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen peroxide induces complex formation of SHC-Grb2-SOS with receptor tyrosine kinase and activates Ras and extracellular signal-regulated protein kinases group of mitogen-activated protein kinases.
Rao GN
Oncogene; 1996 Aug; 13(4):713-9. PubMed ID: 8761292
[TBL] [Abstract][Full Text] [Related]
4. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
5. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc.
Kranenburg O; Verlaan I; Hordijk PL; Moolenaar WH
EMBO J; 1997 Jun; 16(11):3097-105. PubMed ID: 9214627
[TBL] [Abstract][Full Text] [Related]
6. Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells.
Rubio I; Rennert K; Wittig U; Beer K; Dürst M; Stang SL; Stone J; Wetzker R
Biochem J; 2006 Sep; 398(2):243-56. PubMed ID: 16709153
[TBL] [Abstract][Full Text] [Related]
7. A new function for phospholipase C-gamma1: coupling to the adaptor protein GRB2.
Pei Z; Maloney JA; Yang L; Williamson JR
Arch Biochem Biophys; 1997 Sep; 345(1):103-10. PubMed ID: 9281317
[TBL] [Abstract][Full Text] [Related]
8. Ras effector pathway activation by epidermal growth factor is inhibited in vivo by exoenzyme S ADP-ribosylation of Ras.
Henriksson ML; Rosqvist R; Telepnev M; Wolf-Watz H; Hallberg B
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):217-22. PubMed ID: 10727422
[TBL] [Abstract][Full Text] [Related]
9. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
10. Activation of Ras and other signaling pathways by receptor tyrosine kinases.
Schlessinger J; Bar-Sagi D
Cold Spring Harb Symp Quant Biol; 1994; 59():173-9. PubMed ID: 7587067
[No Abstract] [Full Text] [Related]
11. Isoform-specific ras functions in development and cancer.
Quinlan MP; Settleman J
Future Oncol; 2009 Feb; 5(1):105-16. PubMed ID: 19243303
[TBL] [Abstract][Full Text] [Related]
12. Points of convergence between Ca2+ and Ras signalling pathways.
Gawler DJ
Biochim Biophys Acta; 1998 Dec; 1448(2):171-82. PubMed ID: 9920408
[TBL] [Abstract][Full Text] [Related]
13. RTK-RAS pathway mutation is enriched in myeloid sarcoma.
Choi M; Jeon YK; Sun CH; Yun HS; Hong J; Shin DY; Kim I; Yoon SS; Koh Y
Blood Cancer J; 2018 May; 8(5):43. PubMed ID: 29789584
[No Abstract] [Full Text] [Related]
14. Hyperdigraph-theoretic analysis of the EGFR signaling network: initial steps leading to GTP:Ras complex formation.
Oliveira JS; Jones-Oliveira JB; Dixon DA; Bailey CG; Gull DW
J Comput Biol; 2004; 11(5):812-42. PubMed ID: 15700404
[TBL] [Abstract][Full Text] [Related]
15. Fighting cancer by disrupting C-terminal methylation of signaling proteins.
Clarke S; Tamanoi F
J Clin Invest; 2004 Feb; 113(4):513-5. PubMed ID: 14966560
[TBL] [Abstract][Full Text] [Related]
16. Catalysis and regulation.
Noble M; Ladbury JE
Curr Opin Struct Biol; 2011 Dec; 21(6):775-6. PubMed ID: 22142589
[No Abstract] [Full Text] [Related]
17. NADPH Oxidase (NOX) Targeting in Diabetes: A Special Emphasis on Pancreatic β-Cell Dysfunction.
Elumalai S; Karunakaran U; Moon JS; Won KC
Cells; 2021 Jun; 10(7):. PubMed ID: 34206537
[TBL] [Abstract][Full Text] [Related]
18. GPI-AP: Unraveling a New Class of Malignancy Mediators and Potential Immunotherapy Targets.
Hussein NH; Amin NS; El Tayebi HM
Front Oncol; 2020; 10():537311. PubMed ID: 33344222
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in Cancer Treatment-Induced Cardiotoxicity.
Pellegrini L; Sileno S; D'Agostino M; Foglio E; Florio MC; Guzzanti V; Russo MA; Limana F; Magenta A
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32192047
[TBL] [Abstract][Full Text] [Related]
20. A SYK/SHC1 pathway regulates the amount of CFTR in the plasma membrane.
Loureiro CA; Pinto FR; Barros P; Matos P; Jordan P
Cell Mol Life Sci; 2020 Dec; 77(23):4997-5015. PubMed ID: 31974654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
